| Date Filed | Type | Description |
| 05/05/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/20/2023 |
8-K
| Quarterly results |
| 02/14/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 02/06/2023 |
8-K
| Quarterly results |
| 01/18/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 01/03/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/02/2022 |
8-K
| Quarterly results |
| 08/25/2022 |
4
| Cloutier Daniel Danny (Director) has filed a Form 4 on BRAIN SCIENTIFIC INC.|
Txns:
| Granted 362,069 options to buy
@ $0.29, valued at
$105k
Granted 304,608 options to buy
@ $0.12, valued at
$36.6k
|
|
| 08/25/2022 |
3
| Cloutier Daniel Danny (Director) has filed a Form 3 on BRAIN SCIENTIFIC INC. |
| 08/24/2022 |
4
| Olivier Thomas (Director) has filed a Form 4 on BRAIN SCIENTIFIC INC.|
Txns:
| Granted 304,608 options to buy
@ $0.12, valued at
$36.6k
|
|
| 08/24/2022 |
4
| MacKenzie Donald S (Director) has filed a Form 4 on BRAIN SCIENTIFIC INC.|
Txns:
| Granted 304,608 options to buy
@ $0.12, valued at
$36.6k
|
|
| 08/24/2022 |
4
| Kukekov Nickolay V. (Director) has filed a Form 4 on BRAIN SCIENTIFIC INC.|
Txns:
| Granted 304,608 options to buy
@ $0.12, valued at
$36.6k
|
|
| 08/23/2022 |
4
| Anthony Farid (Chief Technology Officer) has filed a Form 4 on BRAIN SCIENTIFIC INC.|
Txns:
| Granted 42,857 options to buy
@ $0.12, valued at
$5.1k
|
|
| 08/22/2022 |
4
| Kotob Hassan (CEO) has filed a Form 4 on BRAIN SCIENTIFIC INC.|
Txns:
| Granted 22,930,987 options to buy
@ $0.12, valued at
$2.8M
|
|
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/11/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 08/04/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/04/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/19/2022 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 07/05/2022 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 06/24/2022 |
PRE 14C
| Form PRE 14C - Other preliminary information statements: |
| 06/15/2022 |
8-K
| Quarterly results |
| 05/23/2022 |
4
| Kotob Hassan (CEO) has filed a Form 4 on BRAIN SCIENTIFIC INC.|
Txns:
| Granted 780,000 options to buy
@ $0.31, valued at
$241.8k
|
|
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/28/2022 |
4
| Anthony Farid (Chief Technology Officer) has filed a Form 4 on BRAIN SCIENTIFIC INC.|
Txns:
| Granted 476,190 options to buy
@ $0.21, valued at
$100k
|
|
| 04/28/2022 |
3
| Anthony Farid (Chief Technology Officer) has filed a Form 3 on BRAIN SCIENTIFIC INC. |
| 04/19/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 04/06/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 04/05/2022 |
4
| Olivier Thomas (Director) has filed a Form 4 on BRAIN SCIENTIFIC INC.|
Txns:
| Granted 362,069 options to buy
@ $0.29, valued at
$105k
|
|
| 04/05/2022 |
3
| Olivier Thomas (Director) has filed a Form 3 on BRAIN SCIENTIFIC INC. |
|